HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Go To Nutraceuticals Well For Fresh Personal-Care Ingredients

This article was originally published in The Rose Sheet

Executive Summary

Just as vitamin C offers value in supplements and in topical skin-care products, there are other ingredients in the nutraceutical space that can transition to personal care, Ameann DeJohn, CEO of consulting firm Ameann Solutions, suggests at SupplySide MarketPlace. Astaxanthin, a carotenoid found in algae and crustaceans, is an example.

You may also be interested in...



Ganeden Claims “Highest Level” Proof For Anti-Aging Probiotic

Ganeden Biotech is optimistic that evidence backing the efficacy of its anti-aging probiotic Bonicel will drive success of the branded ingredient. As regulators and lawsuits target cosmetics companies over claims, science that can withstand these tests becomes more important.

Ganeden Claims “Highest Level” Proof For Anti-Aging Probiotic

Ganeden Biotech is optimistic that evidence backing the efficacy of its anti-aging probiotic Bonicel will drive success of the branded ingredient. As regulators and lawsuits target cosmetics companies over claims, science that can withstand these tests becomes more important.

Science of Beauty: Ganeden Claims “Highest Level” Proof For Anti-Aging Probiotic

Ganeden Biotech is optimistic that evidence backing the efficacy of its anti-aging probiotic Bonicel will drive success of the branded ingredient. As regulators and lawsuits target cosmetics companies over claims, science that can withstand these tests becomes more important.

Related Content

Topics

UsernamePublicRestriction

Register

RS018103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel